To understand the functional relevance of such variations in non-coding regions we assessed their association with gene expression and patients’ outcome and demonstrated that the transcriptomic signature of STAG2 gene was associated with good prognosis in ER-positive/HER2-negative breast cancer. Here, ERBB2 is linked to breast cancer.